BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. PTEN, glucose metabolic process, Breast Cancer, Prostate, Biofuel, Fluoxetine)
Bookmark Forward

QuickView for mammary gland development (biogroup)


Body Atlas

Most Correlated Tissues

Loading...
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Pyloric ulcer
  2. Alpha-1-antitrypsin deficiency
  3. Barrett's esophagus
  4. Vesicular stomatitis Indiana virus disease
  5. Perforation of tympanic membrane
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. CGP 60474
  2. OTS-167
  3. A 443654
  4. ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
  5. flavopiridol
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR122
  2. DROSHA
  3. ANKRD2
  4. PPP2R2C
  5. NOP2
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Expression of miR-206 during the initiation of mammary gland development.
  2. Progress on the miRNA related with mammary gland development and lactation].
  3. Investigating molecular mechanisms of embryonic mammary gland development by bead-implantation in em…
  4. Ectodysplasin/NF-κB signaling in embryonic mammary gland development.
  5. A method for electroporation to study gene function in mammary gland development.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Seroma of the Mammary Gland
  2. Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique
  3. CD133 Expression in Mammary Invasive Ductal Carcinoma
  4. Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a…
  5. CIrCuLAting Dna ESr1 Gene Mutations Analysis
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.